Sign Up to like & get
recommendations!
0
Published in 2019 at "Advances in Therapy"
DOI: 10.1007/s12325-019-01027-z
Abstract: This study aimed to compare the usability of subcutaneous administration of SB4 (an etanercept biosimilar) via prefilled syringe (PFS) and autoinjector (AI) based on injection site pain, patient preference, and safety in patients with rheumatoid…
read more here.
Keywords:
sb4 etanercept;
pfs;
etanercept biosimilar;
prefilled syringe ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "British Journal of Dermatology"
DOI: 10.1111/bjd.15152
Abstract: GP2015 is a proposed etanercept biosimilar.
read more here.
Keywords:
proposed etanercept;
etanercept biosimilar;
gp2015 proposed;
study ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2021-eular.1162
Abstract: Biosimilar drugs has supposed a huge savings in our health systems and there are data that conclude that they work as original molecules when we making these switchings. There are limited studies that analize these…
read more here.
Keywords:
term follow;
etanercept biosimilar;
arthritis;
long term ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2022.992932
Abstract: Background Etanercept biosimilar recombinant human TNF-α receptor II: IgG Fc fusion protein (rhTNFR-Fc) has showed its efficacy and safety in Chinese patients with rheumatoid arthritis. However, data on rhTNFR-Fc's application in juvenile idiopathic arthritis (JIA)…
read more here.
Keywords:
etanercept biosimilar;
rhtnfr;
arthritis;
chinese patients ... See more keywords